Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.

• Authors: Hagop Kantarjian, Charles Schiffer, Dan Jones, Jorge Cortes (Affiliation: Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. hkantarj at mdanderson.org)
• Journal: Blood (Blood) Vol. 111 Issue 4 Pg. 1774-80 (Feb 15 2008) ISSN: 0006-4971 United States
• PMID: 18055868 (Publication Type: Journal Article, Review)

Chemical References

• Enzyme Inhibitors
• Bcr-Abl tyrosine kinase
• Protein-Tyrosine Kinases

Topics

• Chromosome Banding
• DNA Mutational Analysis
• Drug Monitoring
• Enzyme Inhibitors (therapeutic use)
• Gene Rearrangement
• Humans
• In Situ Hybridization, Fluorescence
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, genetics, physiopathology)
• Polymerase Chain Reaction
• Protein-Tyrosine Kinases (antagonists & inhibitors)